The Latest Cardiac and Vascular News
– ARO-APOC3 achieved triglyceride reductions of 74-92% – ARO-ANG3 achieved triglyceride reductions of 29-75% and LCL-C reductions of 29-35% – Company to host upcoming KOL webinars on ARO-APOC3 and ARO-ANG3 PASADENA, Calif.–(BUSINESS WIRE)–Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced positive clinical data from multiple product candidates in its cardiometabolic pipeline at the American […]
− Patients Receiving Investigational ALN-AGT Experienced Dose-Dependent Reductions in Blood Pressure, Confirming Potential for RNAi-Mediated Angiotensinogen (AGT) Silencing as a Novel Therapeutic Approach for Hypertension – − Durable AGT Knockdown Through 12 Weeks Supports a Once Quarterly or Potentially Less Frequent Dosing Regimen – − ALN-AGT Generally Well Tolerated, with […]
TRANSLATE-HF study establishes the potential for broad use of the only SGLT2 inhibitor indicated in patients with heart failure with reduced ejection fraction with and without diabetes WILMINGTON, Del.–(BUSINESS WIRE)–New data from a large, contemporary US hospitalized heart failure (HF) registry confirms that four out of five (81.1%) patients with […]
The new program will launch for members from Vida’s national payer customers in December of this year with a full rollout in January of 2021 SAN FRANCISCO–(BUSINESS WIRE)–Expanding on its commitment to improve health outcomes for millions of lives, Vida Health announced a new app-based, coach-centered virtual congestive heart failure (CHF) management […]
Expanded pivotal Phase 3 REVERSE-IT trial of product candidate bentracimab (PB2452) for reversal of antiplatelet effects of ticagrelor into Canada and dosed first patients outside the United States Resuming enrollment in ongoing Phase 2b trial of pemziviptadil (PB1046) in pulmonary arterial hypertension MALVERN, Pa. & SAN DIEGO–(BUSINESS WIRE)–PhaseBio Pharmaceuticals, Inc. (Nasdaq: […]
SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, the leader in advanced imaging for stroke, today announced unprecedented growth in the adoption and use of the Rapid platform around the world. Now approved in over 60 countries and utilized in over 1,600 hospitals, the company has experienced a year-over-year increase in just International Rapid […]
New 3D mapping and navigation feature allows for high-definition mapping of the full atrium VANCOUVER, British Columbia–(BUSINESS WIRE)–Kardium is pleased to announce the first clinical use of the Globe Positioning System (GPS™) – the new 3D mapping and navigation feature of its flagship product, the Globe® Mapping and Ablation System. […]
Represents Largest Catheter Based Thromboaspiration Study Completed to Date LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, announced the safety and efficacy results from the Registry of AngioVac* System Procedures In Detail (RAPID) database. Results […]
Innovative minimally-invasive therapy is proven to help people with heart failure feel better CHAPEL HILL, N.C.–(BUSINESS WIRE)–UNC Medical Center today announced it is among the first hospitals in the United States and the first hospital in the Carolinas to use CCM® therapy, delivered by the Optimizer® system, to treat patients suffering from heart failure. […]
Acquisition will expand Ambulatory Remote Cardiac ECG Monitoring product technology offering and outreach into US and international markets ESCONDIDO, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) — via InvestorWire – CB Scientific. Inc. (OTC:CBSC) (“CBSC” or the “Company”), a provider of innovative products and services for the ambulatory noninvasive cardiac monitoring […]
